NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
Back to search
Official data from USPTO
MUNTANA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MUNTANA
ST13
US500000098488858Class
1, 5, 42, 44
Filing
98488858
Registration
7972275
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
10/08/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
04/08/2024
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Derio, Vizcaya, ES
Examiner
MARTIN,LIEF ANDREW
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
Representatives
aoi nawashiro FisherBroyles, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Enzymes for industrial purposes; Enzymes for scientific purposes; Enzyme preparations for industrial purposes; Enzyme preparations for scientific purposes; Enzymes for genome editing for scientific and research purposes; Enzymes preparations for genome editing for scientific and research purposes; Diagnostic preparationsother than for medical or veterinary purposes; Reagents for scientific purposes; Reagents for research purposes; Reagents for genome editing for scientific and research purposes; Crispr inhibitors being biochemicalchemicalbiological preparations for scientific and research purposes; Crispr controls being biochemicalchemicalbiological preparations for scientific and research purposes; Crispr reagents for genome editing for scientific and research purposes; Chemical substances for use in the biotechnological industry; Chemical reagents for use in biotechnologyother than for medical or veterinary use; Chemical preparations for use in DNA analysisother than medical use; Enzyme preparations for use in DNA analysisother than medical use; Enzymes for use in DNA analysisother than medical use; Chemical preparations for use in RNA analysisother than medical use; Enzyme preparations for use in RNA analysisother than medical use; Enzymes for use in RNA analysisother than medical use; Enzymes for editing genomes for medical or veterinary research purposes
Class 5
Enzymes for medical purposes; Enzymes for veterinary purposes; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzyme preparations for editing genomes for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Reagents for use in medical genetic testing; Reagents for use in veterinary genetic testing; Reagents for genome editing for medical or veterinary purposes; Crispr inhibitors being biochemicalchemicalbiological preparations for medical or veterinary purposes; Crispr controls being biochemicalchemicalbiological preparations for medical or veterinary purposes; Crispr reagents for genome editing for medical or veterinary purposes; Chemical preparations for use in DNA analysis for medical or veterinary purposes; Enzyme preparations for use in DNA analysis for medical or veterinary purposes; Enzymes for use in DNA analysis for medical or veterinary purposes; Chemical preparations for use in RNA analysis for medical or veterinary purposes; Enzyme preparations for use in RNA analysis for medical or veterinary purposes; Enzymes for use in RNA analysis for medical or veterinary purposes
Class 42
Research in the field of gene therapy; Advisory services relating to gene therapy research; Research in the field of gene editing technology; Advisory services in the field of gene editing technology; Genome editing for scientific purposes; Genome editing for scientific research purposes; Genome editing for industrial purposes; Genome editing for use in biotechnologyother than for medical or veterinary use
Class 44
Genome editing for medical purposes; Genome editing for veterinary purposes
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2025
PUBO
PUBLISHED FOR OPPOSITION
08/19/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/18/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/31/2025
GNSL
LETTER OF SUSPENSION E-MAILED
01/31/2025
CNSL
SUSPENSION LETTER WRITTEN
01/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/21/2024
GNRT
NON-FINAL ACTION E-MAILED
10/21/2024
CNRT
NON-FINAL ACTION WRITTEN
10/21/2024
DOCK
ASSIGNED TO EXAMINER
10/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2024
NWAP
NEW APPLICATION ENTERED
04/08/2024
Continuous trademark protection
Get notified about every new filing that threatens MUNTANA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.